{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:57:03Z","timestamp":1790873823881,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1124\/jpet.122.001631","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:33:42Z","timestamp":1686080022000},"page":"181-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cyclooxygenase Inhibitors and Cancer: The Missing Pieces"],"prefix":"10.1016","volume":"386","author":[{"given":"Carlo","family":"Patrono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001631_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib3","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1053\/j.gastro.2006.08.079","article-title":"A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas","volume":"131","author":"Baron","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.122.001631_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001631_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.annonc.2020.02.012","article-title":"Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019","volume":"31","author":"Bosetti","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1124\/jpet.122.001631_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.smim.2018.10.011","article-title":"Aging, inflammation and cancer","volume":"40","author":"Bottazzi","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1124\/jpet.122.001631_bib1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106506","article-title":"The specific deletion of cyclooxygenase-1 in megakaryocytes\/platelets reduces intestinal polyposis in ApcMin\/+ mice","volume":"185","author":"Bruno","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.122.001631_bib9","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1056\/NEJMoa0801297","article-title":"Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome","volume":"359","author":"Burn","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib10","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001631_bib11","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","article-title":"Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial","volume":"395","author":"Burn","year":"2020","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001631_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2019.08.001","article-title":"The effect of low-dose aspirin on colorectal cancer prevention and gastrointestinal bleeding according to bodyweight and body mass index: Analysis of UK primary care data","volume":"297","author":"Cea Soriano","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1124\/jpet.122.001631_bib13","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jamaoncol.2022.2967","article-title":"Aspirin and the USPSTF-What About Cancer?","volume":"8","author":"Chan","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1124\/jpet.122.001631_bib14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199110173251605","article-title":"Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin","volume":"325","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djn485","article-title":"Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials","volume":"101","author":"Cole","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.122.001631_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.122.001631_bib17","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.5207","article-title":"Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement","volume":"327","author":"Davidson","year":"2022","journal-title":"JAMA"},{"key":"10.1124\/jpet.122.001631_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-med-060319-120913","article-title":"Aspirin in the Prevention of Colorectal Neoplasia","volume":"72","author":"Drew","year":"2021","journal-title":"Annu Rev Med"},{"key":"10.1124\/jpet.122.001631_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI110814","article-title":"Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man","volume":"71","author":"FitzGerald","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.122.001631_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001631_bib23","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1182\/blood-2013-05-468694","article-title":"Platelets in tissue repair: control of apoptosis and interactions with regenerative cells","volume":"122","author":"Gawaz","year":"2013","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001631_bib24","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001631_bib25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S2468-1253(19)30289-4","article-title":"Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial","volume":"4","author":"Joharatnam-Hogan","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1124\/jpet.122.001631_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-023-02310-1","article-title":"Thromboxane Biosynthesis in Cancer Patients and its Inhibition by Aspirin","author":"Joharatnam-Hogan","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.122.001631_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.gastro.2004.05.001","article-title":"Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial","volume":"127","author":"Laine","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.122.001631_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat Med"},{"key":"10.1124\/jpet.122.001631_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.122.001631_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jnci\/djaa114","article-title":"Effect of Aspirin on Cancer Incidence and Mortality in Older Adults","volume":"113","author":"McNeil","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.122.001631_bib31","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of Aspirin on Disability-free Survival in the Healthy Elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of Aspirin on All-Cause Mortality in the Healthy Elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and Cancer","volume":"68","author":"Patrignani","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.122.001631_bib34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/09537104.2018.1492105","article-title":"Aspirin, platelet inhibition and cancer prevention","volume":"29","author":"Patrignani","year":"2018","journal-title":"Platelets"},{"key":"10.1124\/jpet.122.001631_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2015.05.012","article-title":"The Multifaceted Clinical Read-Outs of Platelet Inhibition by Low-Dose Aspirin","volume":"66","author":"Patrono","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.122.001631_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bph.15966","article-title":"Fifty years with aspirin and platelets","volume":"180","author":"Patrono","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001631_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.113.004480","article-title":"Nonsteroidal anti-inflammatory drugs and the heart","volume":"129","author":"Patrono","year":"2014","journal-title":"Circulation"},{"key":"10.1124\/jpet.122.001631_bib38","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib39","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2017.08.037","article-title":"Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis","volume":"70","author":"Patrono","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.122.001631_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI200113418","article-title":"Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs","volume":"108","author":"Patrono","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.122.001631_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7911","article-title":"Platelets subvert T cell immunity against cancer via GARP-TGF\u03b2 axis","volume":"2","author":"Rachidi","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1124\/jpet.122.001631_bib42","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1158\/0008-5472.CAN-21-0758","article-title":"Aspirin in Hepatocellular Carcinoma","volume":"81","author":"Ricciotti","year":"2021","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.122.001631_bib43","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMe1812000","article-title":"Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?","volume":"379","author":"Ridker","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood.2019004596","article-title":"A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia","volume":"136","author":"Rocca","year":"2020","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001631_bib45","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.cgh.2018.12.012","article-title":"Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer","volume":"17","author":"Rodr\u00edguez-Miguel","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1124\/jpet.122.001631_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001631_bib47","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001631_bib48","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001631_bib49","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.119.259382","article-title":"Platelet-Specific Deletion of Cyclooxygenase-1 Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice","volume":"370","author":"Sacco","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001631_bib50","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/ijc.33311","article-title":"Aspirin and the risk of nondigestive tract cancers: An updated meta-analysis to 2019","volume":"148","author":"Santucci","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.122.001631_bib51","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa1912035","article-title":"Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality","volume":"382","author":"Simon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001631_bib52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.122.001631_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1124\/jpet.122.001631_bib54","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524170632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524170632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:30:04Z","timestamp":1739971804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524170632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022356524170632"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001631","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclooxygenase Inhibitors and Cancer: The Missing Pieces","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}